Picture of Sangrix logo

SGRX — Sangrix Cashflow Statement

0.000.00%
us flag iconLast trade - 00:00
Consumer DefensivesHighly SpeculativeMicro CapValue Trap

Annual cashflow statement for Sangrix, fiscal year end - June 30th, USD millions except per share, conversion factor applied.

2022
June 30th
2023
June 30th
2024
June 30th
2025
June 30th
2026
June 30th
Period Length:12 M12 M12 M12 M12 M
Source:20-F20-F20-F20-F20-F
Standards:
USG
USG
USG
USG
USG
Status:FinalFinalFinalFinalFinal
Net Income/Starting Line-2.17-28.2-18.3-4.37-14.3
Depreciation
Non-Cash Items7.7514.913.61.9811.6
Discontinued Operations
Unusual Items
Other Non-Cash Items
Changes in Working Capital-20.21.19-4.170.102-0.237
Change in Accounts Receivable
Change in Prepaid Expenses
Change in Accounts Payable
Change in Payable / Accrued Expenses
Change in Other Liabilities
Net Change in Other Assets & Liabilities
Other Operating Cash Flow
Cash from Operating Activities-14.3-6.76-7.93-2.29-2.92
Capital Expenditures-8.3-0.115———
Purchase of Fixed Assets
Other Investing Cash Flow Items-34.381.021.55-0.2
Acquisition of Business
Sale of Business
Sale/Maturity of Investment
Change in Net Investments
Purchase of Investments
Other Investing Cash Flow
Cash from Investing Activities-11.34.271.021.55-0.2
Financing Cash Flow Items-9.050.128-0.596-0.609-0.646
Other Financing Cash Flow
Net Issuance / Retirement of Stock
Net Issuance / Retirement of Debt
Cash from Financing Activities262.498.3-0.6094.64
Foreign Exchange Effects
Beginning Cash Balance
Ending Cash Balance
Net Change in Cash0.388-0.0021.39-1.351.51